Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H A Lankes

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Applied Microbiology|April 24, 2007
In vivo gene delivery and expression by bacteriophage lambda vectorsH A Lankes, C N Zanghi, K Santos, et al.
Gynecologic Oncology|January 17, 2013
A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: a Gynecologic Oncology Group studyR J Schilder, M W Sill, H A Lankes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2016
A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852)P H Thaker, R Salani, W E Brady, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners studyB J Monk, M F Brady, C Aghajanian, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Applied Microbiology|April 24, 2007
In vivo gene delivery and expression by bacteriophage lambda vectorsH A Lankes, C N Zanghi, K Santos, et al.
Gynecologic Oncology|January 17, 2013
A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: a Gynecologic Oncology Group studyR J Schilder, M W Sill, H A Lankes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2016
A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852)P H Thaker, R Salani, W E Brady, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners studyB J Monk, M F Brady, C Aghajanian, et al.
Pageof 1